Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

Neuro-Oncology
Ugur T. Sener, M.D.
"Von Hippel Lindau Syndrome - Diagnosis, Neurologic Manifestations, and Therapeutic Advances"

Learning objectives:

• Describe pathophysiology of Von Hippel Lindau Disease
• Describe presentation, clinical course, and management of CNS hemangioblastomas associated with the condition
• Review use of belzutifan including indications, expected benefits, and clinical trial results
• Review potential toxicities of belzutifan and monitoring required
• Summarize ongoing research potential future applications for this therapeutic agent

Dr. Sener does not have any relevant financial relationship to disclose and does not intend to discuss an off-label/investigative use of any commercial product/devices.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.